{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:14:02Z","timestamp":1790828042029,"version":"4.1.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00141","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:35:35Z","timestamp":1555374935000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":95,"title":["Extranodal Natural Killer\/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress"],"prefix":"10.3389","volume":"7","author":[{"given":"Yasuaki","family":"Harabuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Kishibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nagato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V","article-title":"Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies","volume":"77","author":"Harabuchi","year":"1996","journal-title":"Cancer."},{"key":"B3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ijc.2910440112","article-title":"Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions","volume":"44","author":"Aozasa","year":"1989","journal-title":"Int J Cancer."},{"key":"B5","first-page":"55","article-title":"Characteristics of nasal T\/NK-cell lymphoma among Brazilians","volume":"49","author":"Altemani","year":"2002","journal-title":"Neoplasma."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/00000478-200011000-00006","article-title":"Sinonasal NK\/T-cell lymphomas in the United States","volume":"24","author":"Gaal","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/000348949910800417","article-title":"Sinonasal malignant lymphomas: a distinct clinicopathological category","volume":"108","author":"Vidal","year":"1999","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V81.10.2688.2688","article-title":"Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus","volume":"81","author":"Kanavaros","year":"1993","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/000348948509400223","article-title":"Midfacial T cell lymphoma: Characterization by monoclonal antibodies","volume":"94","author":"Yamanaka","year":"1985","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/0002-9610(66)90328-X","article-title":"Primary lymphoma of the nose including a relationship to lethal midline granuloma","volume":"112","author":"Eichel","year":"1966","journal-title":"Am J Surg."},{"key":"B12","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","article-title":"CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas","volume":"87","author":"Emile","year":"1996","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1182\/blood.V97.3.708","article-title":"Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T\/NK-cell lymphomas associated with the Epstein-Barr virus","volume":"97","author":"Nagata","year":"2001","journal-title":"Blood."},{"key":"B14","first-page":"S104","article-title":"The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms","volume":"111","author":"Kinney","year":"1999","journal-title":"Am J Clin Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/hon.847","article-title":"Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues","volume":"26","author":"Suzuki","year":"2008","journal-title":"Hematol Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10147-009-0882-7","article-title":"Nasal natural killer (NK)\/T-cell lymphoma: clinical, histological, virological, and genetic features","volume":"14","author":"Harabuchi","year":"2009","journal-title":"Int J Clin Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1099\/0022-1317-75-1-77","article-title":"Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas","volume":"75","author":"Minarovits","year":"1994","journal-title":"J General Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jmv.20853","article-title":"Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK\/T-cell lymphoma","volume":"79","author":"Ishii","year":"2007","journal-title":"J Med Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","article-title":"Extranodal natural killer\/T-cell lymphoma in children and adolescents: a report of 17 cases in China","volume":"145","author":"Huang","year":"2016","journal-title":"Am J Clin Pathol."},{"key":"B20","first-page":"64","article-title":"Photographs of a case of rapid destruction of the nose and face","volume":"12","author":"McBride","year":"1897","journal-title":"J Laryngol Otol."},{"key":"B21","first-page":"43","article-title":"Uber ein eigenartiges granulom aer nasen-, rachen- und mundhohle","volume":"24","author":"Kraus","year":"1929","journal-title":"Verh Dtsch Ges Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/000348944905800405","article-title":"Lethal granulomatous ulceration, involving midline facial tissues","volume":"58","author":"Williams","year":"1949","journal-title":"Ann Otol Rhino Laryngol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/1097-0142(19920815)70:4<835::AID-CNCR2820700419>3.0.CO;2-F","article-title":"Lethal midline granuloma (peripheral T-cell lymphoma) after lymphomatoid papulosis","volume":"70","author":"Harabuchi","year":"1992","journal-title":"Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jcp.30.4.317","article-title":"Pathology of nonhealing (midline) granuloma","volume":"30","author":"Michaels","year":"1977","journal-title":"J Clin Path."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/1097-0142(19821201)50:11<2336::AID-CNCR2820501120>3.0.CO;2-C","article-title":"Nasal T-cell lymphoma as a type of so-called \u201clethal midline granuloma\u201d","volume":"50","author":"Ishii","year":"1982","journal-title":"Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0046-8177(87)80410-0","article-title":"Expression of natural killer cell markers in non-Hodgkin's lymphomas","volume":"18","author":"Ng","year":"1987","journal-title":"Hum Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/hon.2900080505","article-title":"Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type","volume":"8","author":"Ho","year":"1990","journal-title":"Hematol Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00000478-199205000-00002","article-title":"Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions","volume":"16","author":"Medeiros","year":"1992","journal-title":"Am J Surg Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/00000478-199202000-00008","article-title":"Frequency of Epstein-Barr viral DNA in \u201cWestern\u201d sinonasal and Waldeyer's ring non-Hodgkin's lymphoma","volume":"16","author":"Weiss","year":"1992","journal-title":"Am J Surg Pathol."},{"key":"B30","unstructured":"Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China305561 LiuJ SongB FanT HuangC XieC LiJ 22393989Asian Pac J Cancer Prev.122011"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"P. Non-Hodgkin's Lymphoma Classification, Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1750-1172-8-95","article-title":"Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis","volume":"8","author":"Lima","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00000478-199304000-00010","article-title":"Nasal lymphomas in peru. high incidence of T-cell immunophenotype and Epstein-Barr virus infection [see comments]","volume":"17","author":"Arber","year":"1993","journal-title":"Am J Surg Pathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1100\/tsw.2011.41","article-title":"Epidemiology and pathogenesis of nasal NK\/T-cell lymphoma: a mini-review","volume":"11","author":"Aozasa","year":"2011","journal-title":"Sci World J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.0307-7772.2001.00529.x","article-title":"HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis","volume":"27","author":"Goldsmith","year":"2002","journal-title":"Clin Otolaryngol Allied Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<72::AID-IJC11>3.0.CO;2-C","article-title":"Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies","volume":"72","author":"Sidagis","year":"1997","journal-title":"Int J Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000106462","article-title":"Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK\/T cell lymphoma patients","volume":"50","author":"Nagamine","year":"2007","journal-title":"Intervirology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11262-006-0008-5","article-title":"Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK\/T-cell lymphoma","volume":"34","author":"Nagamine","year":"2007","journal-title":"Virus genes."},{"key":"B40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/1097-0215(20000715)87:2<195::AID-IJC6>3.0.CO;2-0","article-title":"Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology","volume":"87","author":"Kanno","year":"2000","journal-title":"Int J Cancer."},{"key":"B41","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ijc.22313","article-title":"Life-style and environmental factors in the development of nasal NK\/T-cell lymphoma: a case-control study in East Asia","volume":"120","author":"Xu","year":"2006","journal-title":"Int J Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1096-8652(200102)66:2<145::AID-AJH1033>3.0.CO;2-V","article-title":"Familial nasal NK\/T-cell lymphoma and pesticide use","volume":"66","author":"Kojya","year":"2001","journal-title":"Am J Hematol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clon.2008.05.011","article-title":"A clinical study of 115 patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"20","author":"Wu","year":"2008","journal-title":"Clin Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.humpath.2003.08.025","article-title":"P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK\/T-cell lymphoma from Hokkaido, Japan","volume":"35","author":"Takahara","year":"2004","journal-title":"Hum Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","article-title":"Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type","volume":"21","author":"Suzuki","year":"2010","journal-title":"Ann Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than international prognostic index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/PAS.0b013e31821ec4b5","article-title":"Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK\/T-cell lymphoma, nasal type, with EBV subtyping analysis","volume":"35","author":"Gualco","year":"2011","journal-title":"Am J Surg Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12185-008-0021-7","article-title":"Nasal NK\/T-cell lymphoma: epidemiology and pathogenesis","volume":"87","author":"Aozasa","year":"2008","journal-title":"Int J Hematol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/000348949610500809","article-title":"Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma","volume":"105","author":"Harabuchi","year":"1996","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the workshop on nasal and related extranodal angiocentric T\/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am J Surg Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/1097-0142(19880815)62:4<705::AID-CNCR2820620410>3.0.CO;2-Z","article-title":"Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. evidence for a monoclonal T-cell lymphoproliferative disorder","volume":"62","author":"Gaulard","year":"1988","journal-title":"Cancer."},{"key":"B52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2133.1999.02718.x","article-title":"Nasal-type T\/natural killer cell angiocentric lymphoma, Epstein-Barr virus-associated, and showing clonal T-cell receptor gamma gene rearrangement","volume":"140","author":"Yoon","year":"1999","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y","article-title":"Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease","volume":"68","author":"Chiang","year":"1996","journal-title":"Int J Cancer."},{"key":"B54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1046\/j.1320-5463.2003.01552.x","article-title":"Comparative analysis of NK\/T-cell lymphoma and peripheral T-cell lymphoma in Korea: clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1","volume":"53","author":"Kim","year":"2003","journal-title":"Pathol Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1365-2141.1997.752711.x","article-title":"Clonal chromosomal abnormalities as direct evidence for clonality in nasal T\/natural killer cell lymphomas","volume":"97","author":"Tien","year":"1997","journal-title":"Br J Haematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1046\/j.1365-2141.1997.3223139.x","article-title":"Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia","volume":"98","author":"Wong","year":"1997","journal-title":"Br J Haematol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","article-title":"Consistent patterns of allelic loss in natural killer cell lymphoma","volume":"157","author":"Siu","year":"2000","journal-title":"Am J Pathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1046\/j.1365-2141.2003.04419.x","article-title":"A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer\/T-cell lymphoma","volume":"122","author":"Sun","year":"2003","journal-title":"Br J Haematol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1038\/sj.onc.1205571","article-title":"Frequent mutations of Fas gene in nasal NK\/T cell lymphoma","volume":"21","author":"Takakuwa","year":"2002","journal-title":"Oncogene."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/S0002-9440(10)64490-2","article-title":"Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer\/T-cell lymphoma","volume":"161","author":"Shen","year":"2002","journal-title":"Am J Pathol."},{"key":"B62","unstructured":"p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK\/T-cell lymphoma in Korea and Japan26571 HongyoT HoshidaY NakatsukaS SyaifudinM KojyaS YangWI 15643509Oncology reports.132005"},{"key":"B63","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/labinvest.3780055","article-title":"Mutations of the p53 gene in nasal NK\/T-cell lymphoma","volume":"80","author":"Li","year":"2000","journal-title":"Lab Invest."},{"key":"B64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1349-7006.2003.tb01436.x","article-title":"Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China","volume":"94","author":"Hoshida","year":"2003","journal-title":"Cancer Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am J Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1158\/1078-0432.CCR-05-1426","article-title":"Expression of interleukin-9 in nasal natural killer\/T-cell lymphoma cell lines and patients","volume":"11","author":"Nagato","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1158\/0008-5472.CAN-04-0733","article-title":"Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1002\/ijc.22139","article-title":"Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3","volume":"119","author":"Takahara","year":"2006","journal-title":"Int J Cancer."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-09-1052","article-title":"Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer\/T-cell lymphoma cells","volume":"15","author":"Moriai","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00262-015-1675-7","article-title":"CCL17 and CCL22\/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer\/T-cell lymphoma","volume":"64","author":"Kumai","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2407-7-229","article-title":"The enhanced expression of the matrix metalloproteinase 9 in nasal NK\/T-cell lymphoma","volume":"7","author":"Sakata","year":"2007","journal-title":"BMC Cancer."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/1535-7163.MCT-05-0253","article-title":"Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas","volume":"4","author":"Israel","year":"2005","journal-title":"Mol Cancer Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bjh.12136","article-title":"Expression of CD70 in nasal natural killer\/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27","volume":"160","author":"Yoshino","year":"2013","journal-title":"Br J Haematol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1073\/pnas.1713607115","article-title":"Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4(+) and CD8(+) T cell responses","volume":"115","author":"Choi","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1158\/2159-8290.CD-14-0474","article-title":"Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions","volume":"5","author":"Liou","year":"2015","journal-title":"Cancer Discov."},{"key":"B77","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.exphem.2013.03.009","article-title":"Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK\/T cell lymphoma cells","volume":"41","author":"Takahara","year":"2013","journal-title":"Exp Hematol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ajh.23570","article-title":"Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK\/T-cell lymphoma","volume":"89","author":"Komabayashi","year":"2014","journal-title":"Am J Hematol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ijc.25969","article-title":"Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer\/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15","volume":"130","author":"Ishii","year":"2012","journal-title":"Int J Cancer."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00262-017-1987-x","article-title":"Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer\/T-cell lymphoma: a potential rationale for immunotherapy","volume":"66","author":"Nagato","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"B82","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4049\/jimmunol.164.2.762","article-title":"Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages","volume":"164","author":"Sica","year":"2000","journal-title":"J Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1365-2141.2000.02344.x","article-title":"Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies","volume":"111","author":"Lei","year":"2000","journal-title":"Br J Haematol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","article-title":"Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood."},{"key":"B85","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/hon.2360","article-title":"Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer\/T-cell lymphoma","volume":"35","author":"Komabayashi","year":"2017","journal-title":"Hematol Oncol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J Hematol Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer."},{"key":"B88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3960\/jslrt.41.93","article-title":"Treatment outcome of nasal NK-cell lymphoma: a case report of 12 consecutively-diagnosed cases and a review of the literature","volume":"41","author":"Yamaguchi","year":"2001","journal-title":"J Clin Exp Hematopathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer."},{"key":"B90","first-page":"1","article-title":"Advances in the management of hemophagocytic lymphohistiocytosis","volume":"72","author":"Imashuku","year":"2000","journal-title":"Int J Hematol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: japan clinical oncology group study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J Clin Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","article-title":"Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia","volume":"99","author":"Yamaguchi","year":"2008","journal-title":"Cancer Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1634\/theoncologist.2014-0305","article-title":"A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I\/II extranodal natural killer\/T-cell lymphoma, nasal type: a multicenter trial of the Korean cancer study group","volume":"19","author":"Kim","year":"2014","journal-title":"Oncologist."},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ebiom.2017.10.011","article-title":"A phase II study of methotrexate, etoposide, dexamethasone and pegaspargase sandwiched with radiotherapy in the treatment of newly diagnosed, stage ie to iie extranodal natural-killer\/T-cell lymphoma, nasal-type","volume":"25","author":"Xu","year":"2017","journal-title":"EBioMed."},{"key":"B95","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/hon.2325","article-title":"A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer\/T-cell lymphoma, nasal type: a multicenter trial in Northwest China","volume":"35","author":"Liang","year":"2017","journal-title":"Hematol Oncol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"50155","DOI":"10.18632\/oncotarget.16334","article-title":"A phase II prospective study of the \u201cSandwich\u201d protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I\/II stage, nasal type, extranodal natural killer\/T-cell lymphoma","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget."},{"key":"B97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijrobp.2018.05.046","article-title":"Phase 2 study of first-line intensity modulated radiation therapy followed by gemcitabine, dexamethasone, and cisplatin for high-risk, early stage extranodal nasal-type nk\/t-cell lymphoma: the green study","volume":"102","author":"Qi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B98","doi-asserted-by":"publisher","first-page":"55721","DOI":"10.18632\/oncotarget.10124","article-title":"Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer\/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget."},{"key":"B99","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1158\/1078-0432.CCR-16-0153","article-title":"DDGP versus SMILE in newly diagnosed advanced natural killer\/T-cell lymphoma: a randomized controlled, multicenter, open-label study in China","volume":"22","author":"Li","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1080\/10428190127500","article-title":"High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas","volume":"42","author":"Takenaka","year":"2001","journal-title":"Leukemia lymphoma"},{"key":"B101","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05651.x","article-title":"Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms","volume":"130","author":"Murashige","year":"2005","journal-title":"Br J Haematol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","article-title":"Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms","volume":"37","author":"Suzuki","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B103","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","article-title":"Treatments and outcomes of patients with extranodal natural killer\/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan","volume":"35","author":"Yamaguchi","year":"2017","journal-title":"J Clin Oncol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hon.2273","article-title":"Novel treatment for early-stage nasal natural killer\/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy","volume":"35","author":"Takahara","year":"2017","journal-title":"Hematol Oncol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3760\/cma.j.issn.0253-2727.2018.05.015","article-title":"[Combination of PD-1 inhibitor and chemotherapy in the treatment of nasal NK\/T cell lymphoma: 5 cases report and literature review]","volume":"39","author":"Liu","year":"2018","journal-title":"Zhonghua xue ye xue za zhiZhonghua xueyexue zazhi."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.11.001","article-title":"Peptide vaccines in cancer-old concept revisited","volume":"45","author":"Kumai","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1158\/0008-5472.CAN-07-3212","article-title":"Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells","volume":"68","author":"Kobayashi","year":"2008","journal-title":"Cancer Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e976077","DOI":"10.4161\/2162402X.2014.976077","article-title":"c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK\/T cell lymphoma","volume":"4","author":"Kumai","year":"2015","journal-title":"Oncoimmunology."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e63566","DOI":"10.1371\/journal.pone.0063566","article-title":"Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma","volume":"8","author":"Murata","year":"2013","journal-title":"PloS one."},{"key":"B111","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2326-6066.CIR-16-0194","article-title":"Optimization of peptide vaccines to induce robust antitumor CD4 T-cell responses","volume":"5","author":"Kumai","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/imt.15.103","article-title":"Novel targets for natural killer\/T-cell lymphoma immunotherapy","volume":"8","author":"Kumai","year":"2016","journal-title":"Immunotherapy."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00141\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T13:32:20Z","timestamp":1574515940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00141\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":112,"alternative-id":["10.3389\/fped.2019.00141"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00141","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"article-number":"141"}}